Clinical Trials Directory

Trials / Completed

CompletedNCT01184703

Low Glycemic Index Diet in Patients With Type 1 Diabetes

Effects of a Low Glycemic Index Diet on HbA1c and Lipids in Patients With Type I Diabetes

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
65 (actual)
Sponsor
Steno Diabetes Center Copenhagen · Academic / Other
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to investigate if a low glycemic index diet in comparison with a medium/high glycemic index diet improves the metabolic control in patients with type 1 diabetes.

Detailed description

The glycemic index (GI) was introduced by Jenkins and co-workers in the early 1980s, and is a concept for ranking of carbohydrate foods based on their effect on postprandial glycaemia. A meta-analysis of randomised controlled trials of the effect of low GI diets in the management of diabetes showed a beneficial effect (i.e., a reduction in HbA1c) of low GI versus high GI foods. However, several critical points concerning the GI concept remain, for instance, how to apply it in practical every day life, how to calculate GI in mixed meals, how to find relevant low GI foods, how to ensure compliance to a low GI diet. The most important issue, however, is the fact that studies on the long-term effects of a low GI diet in type 1 diabetes are lacking. In this study, the critical issue of finding palatable low GI foods will be solved in close collaboration with the food industry. This may lead to the development of new commercial products with low GI, which is necessary if low GI diets are to be advocated for diabetics in the future. Comparison(s): A low glycemic index diet, compared to a medium/normal glycemic index diet.

Conditions

Interventions

TypeNameDescription
OTHERLow GI foodComparison of carbohydrates in diabetic patients

Timeline

Start date
2007-06-01
Primary completion
2009-08-01
Completion
2009-12-01
First posted
2010-08-19
Last updated
2010-09-06

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01184703. Inclusion in this directory is not an endorsement.